Xiaolin Xu graduated from the University of Kentucky in May 2020 and then joined Dr. Ho’s lab as a master’s student. She is doing her research on breast cancer drug therapy using Gemcitabine and Paclitaxel nanoparticles with other team members.
Xiaolin Xu graduated from the University of Kentucky in May 2020 and then joined Dr. Ho’s lab as a master’s student. She is doing her research on breast cancer drug therapy using Gemcitabine and Paclitaxel nanoparticles with other team members.